IL136055A0 - Fibroblast growth factor -19 - Google Patents

Fibroblast growth factor -19

Info

Publication number
IL136055A0
IL136055A0 IL13605598A IL13605598A IL136055A0 IL 136055 A0 IL136055 A0 IL 136055A0 IL 13605598 A IL13605598 A IL 13605598A IL 13605598 A IL13605598 A IL 13605598A IL 136055 A0 IL136055 A0 IL 136055A0
Authority
IL
Israel
Prior art keywords
polypeptides
present
methods
treatment
diagnosis
Prior art date
Application number
IL13605598A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL136055A0 publication Critical patent/IL136055A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/50Fibroblast growth factor [FGF]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL13605598A 1997-11-25 1998-11-25 Fibroblast growth factor -19 IL136055A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6684097P 1997-11-25 1997-11-25
US15834298A 1998-09-21 1998-09-21
PCT/US1998/025190 WO1999027100A1 (en) 1997-11-25 1998-11-25 Fibroblast growth factor-19

Publications (1)

Publication Number Publication Date
IL136055A0 true IL136055A0 (en) 2001-05-20

Family

ID=26747212

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13605598A IL136055A0 (en) 1997-11-25 1998-11-25 Fibroblast growth factor -19
IL193366A IL193366A0 (en) 1997-11-25 2008-08-11 Fibroblast growth factor -19

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL193366A IL193366A0 (en) 1997-11-25 2008-08-11 Fibroblast growth factor -19

Country Status (11)

Country Link
EP (1) EP1032668B1 (de)
JP (1) JP3653469B2 (de)
KR (2) KR100506786B1 (de)
AT (1) ATE397063T1 (de)
AU (1) AU733222B2 (de)
CA (1) CA2309783C (de)
DE (1) DE69839571D1 (de)
DK (1) DK1032668T3 (de)
IL (2) IL136055A0 (de)
NZ (1) NZ504425A (de)
WO (1) WO1999027100A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605441B1 (en) 1995-06-05 2003-08-12 Human Genome Sciences, Inc. Antibodies against fibroblast growth factor 11
US6787640B2 (en) 1995-06-05 2004-09-07 Human Genome Sciences, Inc. Fibroblast growth factor 14
US20050043234A1 (en) 1996-10-16 2005-02-24 Deisher Theresa A. Novel FGF homologs
KR100506786B1 (ko) * 1997-11-25 2005-08-08 제넨테크, 인크. 섬유아세포 성장인자-19
AU3900000A (en) * 1999-03-19 2000-10-09 Chiron Corporation Human fgf gene and gene expression products
JP2003501087A (ja) * 1999-06-09 2003-01-14 ジェネンテック・インコーポレーテッド 腫瘍の治療のための組成物と方法
US7459540B1 (en) * 1999-09-07 2008-12-02 Amgen Inc. Fibroblast growth factor-like polypeptides
PT1214409E (pt) * 1999-09-08 2006-10-31 Genentech Inc Acidos nucleicos e polipeptidos do factor de crescimento de fibroblastos-19 (fgf-19) e metodos de utilizacao para o tratamento de obesidade
EP1214409B1 (de) * 1999-09-08 2006-05-17 Genentech, Inc. Fibroblasten-wachstumsfaktor-19 (fgf-19) nukleinsäure und polypeptide und verfahren zu deren verwendung für behandlung von fettleibigkeit
JP2003516731A (ja) * 1999-11-18 2003-05-20 カイロン コーポレイション ヒトfgf−21遺伝子および遺伝子発現産物
US6716626B1 (en) 1999-11-18 2004-04-06 Chiron Corporation Human FGF-21 nucleic acids
AU2759201A (en) * 2000-01-05 2001-07-16 Zymogenetics Inc. Novel fgf homolog zfgf12
AU2631001A (en) * 2000-01-05 2001-07-16 Zymogenetics Inc. Novel fgf homolog zfgf11
EP1947182A1 (de) * 2000-02-15 2008-07-23 Amgen Inc. Fibroblastenwachstumsfaktor-23-Moleküle und ihre Verwendung
EP1257645A2 (de) * 2000-02-15 2002-11-20 Amgen Inc. Fibroblasten wachstumfaktor-23 moleküle und ihre verwendungen
CN1311212A (zh) * 2000-03-02 2001-09-05 上海博德基因开发有限公司 一种新的多肽——人成纤维细胞生长因子14和编码这种多肽的多核苷酸
DK1286704T3 (da) * 2000-06-02 2014-09-22 Univ Texas Ethylendicystein (EC)-glucose analoge konjugater
US20030045489A1 (en) * 2000-11-22 2003-03-06 Murphy John E. Methods for modulating angiogenesis
FI20011542A7 (fi) * 2001-07-13 2003-01-14 Fit Biotech Oyj Plc Uroginaasigeenin monistuman käyttö
MXPA04012243A (es) 2002-06-07 2005-02-25 Genentech Inc Composiciones y metodos para l diagnostico y tratamiento de tumores.
US20040136970A1 (en) 2002-10-07 2004-07-15 Ellsworth Jeff L. Methods for administering FGF18
US7678373B2 (en) 2006-02-10 2010-03-16 Genentech, Inc. Anti-FGF19 antibodies and methods using same
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
NZ582619A (en) 2007-08-03 2012-08-31 Genentech Inc Humanized anti-fgf19 antagonists and methods using same
US8591455B2 (en) 2008-02-21 2013-11-26 Dexcom, Inc. Systems and methods for customizing delivery of sensor data
MX2010013333A (es) 2008-06-04 2011-04-05 Amgen Inc Mutantes fgf21 y usos de los mismos.
EP2358790B2 (de) 2008-12-16 2016-09-21 Dow Corning Corporation Herstellung von siloxanen
US20120052069A1 (en) 2009-05-05 2012-03-01 Amgen Inc Fgf21 mutants and uses thereof
TWI560197B (en) 2009-05-05 2016-12-01 Amgen Inc Fgf21 mutants and uses thereof
WO2010148142A1 (en) * 2009-06-17 2010-12-23 Amgen Inc. Chimeric fgf19 polypeptides and uses thereof
CN102656266B (zh) * 2009-10-15 2016-08-03 霍夫曼-拉罗奇有限公司 具有改变的受体特异性的嵌合成纤维细胞生长因子
UA109888C2 (uk) 2009-12-07 2015-10-26 ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
TWI670283B (zh) 2013-12-23 2019-09-01 美商建南德克公司 抗體及使用方法
EP3108893A1 (de) * 2015-06-25 2016-12-28 Universite Claude Bernard - Lyon 1 Neuartige therapeutische verwendung von fgf19
KR102315601B1 (ko) 2020-05-13 2021-10-21 전남대학교산학협력단 재조합 벡터 및 이를 이용한 재조합 섬유아세포 성장인자 19의 제조 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999014328A2 (en) * 1997-09-17 1999-03-25 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO1999014327A2 (en) * 1997-09-17 1999-03-25 Genentech, Inc. Genes amplified in tumours, antibodies against the proteins coded thereby, and their use in diagnosis and treatment of cancer
KR100506786B1 (ko) * 1997-11-25 2005-08-08 제넨테크, 인크. 섬유아세포 성장인자-19
MXPA01002545A (es) * 1998-09-10 2005-08-16 Genentech Inc Composiciones y metodos para el tratamiento de tumores.
IL141535A0 (en) * 1998-09-16 2002-03-10 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same

Also Published As

Publication number Publication date
WO1999027100A1 (en) 1999-06-03
CA2309783A1 (en) 1999-06-03
KR100506786B1 (ko) 2005-08-08
EP1032668B1 (de) 2008-05-28
IL193366A0 (en) 2009-02-11
DE69839571D1 (de) 2008-07-10
WO1999027100A9 (en) 2000-05-11
KR20010032405A (ko) 2001-04-16
JP2002503446A (ja) 2002-02-05
KR20050009764A (ko) 2005-01-25
CA2309783C (en) 2011-06-28
ATE397063T1 (de) 2008-06-15
AU733222B2 (en) 2001-05-10
DK1032668T3 (da) 2008-09-29
JP3653469B2 (ja) 2005-05-25
NZ504425A (en) 2001-10-26
AU1703399A (en) 1999-06-15
EP1032668A1 (de) 2000-09-06

Similar Documents

Publication Publication Date Title
IL193366A0 (en) Fibroblast growth factor -19
WO2000053755A3 (en) Compositions and methods for the treatment of tumor
DK1623990T3 (da) Sammensætninger og fremgangsmåder til tumorbehandling
AU4851900A (en) Compositions and methods for the treatment of tumor
IL186154A0 (en) Methods and compositions for inhibiting neoplastic cell growth
WO2000073348A3 (en) Methods and compositions for inhibiting neoplastic cell growth
KR100473550B1 (en) Compositions and Methods for The Treatment of Tumor
WO2000037640A3 (en) Compositions and methods for the treatment of tumor
DE60120500D1 (de) In Knorpelgeweben stark exprimiertes Gen
WO2000032778A3 (en) Methods and compositions for inhibiting neoplastic cell growth
EP1820860A3 (de) Verfahren und Zusammensetzungen zur Hemmung des neoplastischen Zellenwachstums

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired